文献速递乳房整形与再造

抗粘连剂对植入物乳房再造中包膜形成的影响:一项随机对照试验

Effects of an Antiadhesive Agent on Capsule Formation in Implant-Based Breast Reconstruction: A Randomized Controlled Trial.
PubMed 文献 · Plast Reconstr Surg · 2022-12-05

该随机对照试验纳入2018年11月至2019年3月因乳腺恶性肿瘤行全乳切除后即刻两阶段植入物乳房再造的患者48例,随机分为对照组22例和抗粘连剂组26例。抗粘连剂组在组织扩张器周围应用Mediclore后,肌肉下包膜厚度显著低于对照组,且包膜内促包膜形成细胞水平显著降低。结论认为抗粘连剂可减轻植入物乳房再造中的包膜形成。

要点

  • 抗粘连剂组肌肉下包膜厚度较对照组显著降低。
  • 抗粘连剂组包膜内肌成纤维细胞、成纤维细胞和M1巨噬细胞水平显著低于对照组。
  • 两组患者相关和手术相关特征无显著差异。

核心结论

  • 抗粘连剂降低了组织扩张期间假体周围包膜的厚度,并改变了参与包膜形成的细胞谱。
  • 这些发现证明抗粘连剂在减轻植入物乳房再造中包膜形成方面具有临床价值。

研究设计与样本

  • 前瞻性随机对照试验,纳入2018年11月至2019年3月因乳腺恶性肿瘤行全乳切除后即刻两阶段植入物乳房再造的患者。
  • 患者随机分配至对照组(n=22)或抗粘连剂组(n=26),在置入乳房扩张器和脱细胞真皮基质后、关闭皮肤前于扩张器周围应用抗粘连剂Mediclore。
  • 在扩张器-假体更换时获取包膜标本,研究包膜厚度和免疫组织化学。

主要发现

  • 共纳入48例患者,对照组22例,抗粘连剂组26例。
  • 两组患者相关和手术相关特征无显著差异。
  • 抗粘连剂组肌肉下包膜厚度较对照组显著降低。
  • 抗粘连剂组包膜内促包膜形成细胞(肌成纤维细胞、成纤维细胞和M1巨噬细胞)水平显著低于对照组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although implant-based breast reconstruction is a common surgical modality, a periprosthetic capsule inevitably forms and worsens in cases of postmastectomy radiation therapy. Previous animal studies have reported that antiadhesive agents (AAAs) inhibit periprosthetic capsule formation. The authors prospectively examined the clinical effects of an AAA (Mediclore) on capsule formation in implant-based breast reconstruction. METHODS: The authors analyzed patients who underwent immediate two-stage implant-based breast reconstruction following total mastectomy for breast malignancy between November of 2018 and March of 2019. Each patient was randomly allocated to the control or AAA group. After inserting the breast expander and acellular dermal matrix, AAA was applied around the expander before skin closure. The capsule specimen was obtained during the expander-implant change; capsule thickness and immunohistochemistry were investigated. RESULTS: A total of 48 patients were enrolled and allocated to the control ( n = 22) and AAA ( n = 26) groups. There were no significant differences in patient- and operation-related characteristics. Submuscular capsule thickness was significantly reduced in the AAA group compared with the control group. The levels of pro-capsular-forming cells (myofibroblasts, fibroblasts, and M1 macrophages) in the capsule were significantly lower in the AAA group than in the control group. CONCLUSIONS: AAA reduced the thickness of periprosthetic capsules and changed the profiles of cells involved in capsule formation during the tissue expansion. These findings demonstrate the clinical value of AAA for mitigating capsule formation in implant-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hong KY, Kim IK, Sakong Y, et al. Effects of an Antiadhesive Agent on Capsule Formation in Implant-Based Breast Reconstruction: A Randomized Controlled Trial. Plast Reconstr Surg. 2022. PMID: 36729974. doi:10.1097/PRS.0000000000009985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。